Search results for "temi"

showing 10 items of 3194 documents

Development of resistance towards artesunate in MDA-MB-231 human breast cancer cells.

2011

Breast cancer is the most common cancer and the second leading cause of cancer death in industrialized countries. Systemic treatment of breast cancer is effective at the beginning of therapy. However, after a variable period of time, progression occurs due to therapy resistance. Artesunate, clinically used as anti-malarial agent, has recently revealed remarkable anti-tumor activity offering a role as novel candidate for cancer chemotherapy. We analyzed the anti-tumor effects of artesunate in metastasizing breast carcinoma in vitro and in vivo. Unlike as expected, artesunate induced resistance in highly metastatic human breast cancer cells MDA-MB-231. Likewise acquired resistance led to abol…

Cancer ResearchPhytochemistryPhytopharmacologyCancer TreatmentArtesunateApoptosisElectrophoretic Mobility Shift AssayDrug resistanceNude MiceMetastasischemistry.chemical_compoundMiceMolecular Cell BiologyDrug DiscoveryBreast TumorsBasic Cancer ResearchMedicinebcl-2-Associated X ProteinMultidisciplinaryQRNF-kappa BArtemisininsChemistryOncologyMedicineFemaleMatrix Metalloproteinase 1Breast carcinomamedicine.drugResearch Article570Drugs and DevicesDrug Research and DevelopmentCell SurvivalScienceMice Nude570 Life SciencesBreast NeoplasmsTumor Cell Line610 Medical Sciences MedicineBreast cancerComplementary and Alternative MedicineCell Line TumorAnimalsHumansDoxorubicinBiologyNeoplasm Drug Resistancebusiness.industryCancers and NeoplasmsChemotherapy and Drug Treatmentmedicine.diseaseXenograft Model Antitumor AssaysTranscription Factor AP-1chemistryTumor progressionArtesunateDrug Resistance NeoplasmCancer cellImmunologyEthnopharmacologyCancer researchbusinessPloS one
researchProduct

Artesunate induces oxidative DNA damage, sustained DNA double-strand breaks, and the ATM/ATR damage response in cancer cells.

2011

Abstract Artesunate, the active agent from Artemisia annua L. used in the traditional Chinese medicine, is being applied as a first-line drug for malaria treatment, and trials are ongoing that include this drug in cancer therapy. Despite increasing interest in its therapeutic application, the mode of cell killing provoked by artesunate in human cells is unknown. Here, we show that artesunate is a powerful inducer of oxidative DNA damage, giving rise to formamidopyrimidine DNA glycosylase–sensitive sites and the formation of 8-oxoguanine and 1,N6-ethenoadenine. Oxidative DNA damage was induced in LN-229 human glioblastoma cells dose dependently and was paralleled by cell death executed by ap…

Cancer ResearchProgrammed cell deathDNA RepairRAD51Drug Evaluation PreclinicalArtesunateApoptosisCell Cycle ProteinsAtaxia Telangiectasia Mutated ProteinsBiologyProtein Serine-Threonine KinasesModels Biologicalchemistry.chemical_compoundNeoplasmsTumor Cells CulturedHumansDNA Breaks Double-StrandedTumor Suppressor ProteinsMolecular biologyAntineoplastic Agents PhytogenicArtemisininsUp-RegulationNon-homologous end joiningDNA-Binding ProteinsOxidative StressCell killingOncologychemistryArtesunateApoptosisCancer cellHomologous recombinationDNA DamageMolecular cancer therapeutics
researchProduct

Early prediction of pancreatic cancer from new-onset diabetes: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)…

2021

Pancreatic cancer (PC) is a common cause of cancer-related death, due to difficulties in detecting early-stage disease, to its aggressive behaviour, and to poor response to systemic therapy. Therefore, developing strategies for early diagnosis of resectable PC is critical for improving survival. Diabetes mellitus is another major public health problem worldwide. Furthermore, diabetes can represent both a risk factor and a consequence of PC: nowadays, the relationship between these two diseases is considered a high priority for research. New-onset diabetes can be an early manifestation of PC, especially in a thin adult without a family history of diabetes. However, even if targeted screening…

Cancer Researchmedicine.medical_specialtyConsensusReviewDiseaseMedical OncologySystemic therapyNOconsensus; diabetes; early diagnosis; hyperglycaemia; pancreatic carcinoma; Consensus; Humans; Medical Oncology; Diabetes Mellitus; Pancreatic Neoplasms; PhysiciansDiabetes mellitusPancreatic cancerPhysiciansmedicineDiabetes MellitusHumansFamily historyRisk factorLS4_3Intensive care medicinediabetes pancreatic carcinoma early diagnosis consensus hyperglycaemiadiabetespancreatic carcinomabusiness.industryPublic healthmedicine.diseasePancreatic NeoplasmsOncologyPosition paperbusinesshyperglycaemiaearly diagnosis
researchProduct

Dexamethasone lacks effect on blood pressure in mice with a disrupted endothelial NO synthase gene.

2003

Cushing's syndrome and systemic administration of glucocorticoids are associated with hypertension, but the underlying molecular mechanism is only partially understood. We have shown previously that dexamethasone downregulates the expression of the endothelial NO synthase (eNOS) gene in human endothelial cells and in the rat and that this may contribute to the blood pressure-raising effect of the steroid [Proc. Natl. Acad. Sci. USA 96 (1999) 13357]. In the current communication, we demonstrated that dexamethasone increased mean arterial blood pressure in wild-type C-57 Bl6 mice (eNOS+/+ mice), but had no effect on blood pressure in mice with a disrupted eNOS gene (eNOS-/- mice) derived from…

Cancer Researchmedicine.medical_specialtyEndotheliumNitric Oxide Synthase Type IIIPhysiologyClinical BiochemistryNitric Oxide Synthase Type IIBlood PressureBiologyKidneyNitric OxideBiochemistryDexamethasoneMiceDownregulation and upregulationEnosInternal medicinemedicineAnimalsEnzyme InhibitorsDexamethasoneMice KnockoutKidneyMyocardiumNitric Oxide Synthase Type IIIbiology.organism_classificationmedicine.anatomical_structureBlood pressureEndocrinologyLiverPharmacogeneticsHypertensionSystemic administrationNitric Oxide Synthasemedicine.drugNitric oxide : biology and chemistry
researchProduct

Factors determining sensitivity or resistance of tumor cell lines towards artesunate.

2009

Clinical oncology is still challenged by the development of drug resistance of tumors that result in poor prognosis for patients. There is an urgent necessity to understand the molecular mechanisms of resistance and to develop novel therapy strategies. Artesunate (ART) is an anti-malarial drug, which also exerts profound cytotoxic activity towards cancer cells. We first applied a gene-hunting approach using cluster and COMPARE analyses of microarray-based transcriptome-wide mRNA expression profiles. Among the genes identified by this approach were genes from diverse functional groups such as structural constituents of ribosomes (RPL6, RPL7, RPS12, RPS15A), kinases (CABC1, CCT2, RPL41), tran…

Candidate geneOncogeneCell growthAngiogenesisKinaseCellArtesunateGeneral MedicineDrug resistancePharmacologyBiologyToxicologyAntineoplastic Agents PhytogenicArtemisininsDrug Resistance MultipleAntimalarialsmedicine.anatomical_structureDrug Resistance NeoplasmCell Line TumorNeoplasmsCancer cellmedicineHumansChemico-biological interactions
researchProduct

Analysis of the mechanical performance of hybrid (SPR/bonded) single-lap joints between CFRP panels and aluminum blanks

2013

Abstract The increasing use of innovative materials in manufacturing of modern mechanical components has led to the development of reliable joints between innovative (composite materials etc.) and traditional materials (steel, aluminum etc.). In the last few years, hybrid joints, combining the advantages of the adhesive joints and traditional mechanical joints as bolted or riveted joints, have been shown an increasing industrial interest especially in automotive and aerospace sectors. In the present paper a systematic experimental study of hybrid lap joints was carried out with the aim to detect the optimal joint configuration. Tensile tests on hybrid joints made by combining adhesive bondi…

Carbon fiber reinforced polymerMaterials sciencePolymers and PlasticsAdhesive bondingbusiness.industryGeneral Chemical EngineeringHybrid jointStructural engineeringbondingBiomaterialsSettore ING-IND/14 - Progettazione Meccanica E Costruzione Di MacchineLap jointMechanical jointUltimate tensile strengthRivetself piercing rivetingAdhesiveComposite materialbusinessSettore ING-IND/16 - Tecnologie E Sistemi Di LavorazioneJoint (geology)International Journal of Adhesion and Adhesives
researchProduct

Systemic therapies for hepatocellular carcinoma: The present and the future

2021

Hepatocellular carcinoma is diagnosed in more than half of all cases at unresectable stage when no potentially curative treatments are feasible. Since 2008, sorafenib had represented the only effective first line systemic therapy over the last decade until the approval of lenvatinib, who showed to be non-inferior to sorafenib. Recently, for the first time, a combination of immunotherapy and antiangiogenic drug, atezolizumab plus bevacizumab, was associated with a significantly longer overall survival and progression free survival compared to sorafenib, becoming the new best performing first-line approach for unresectable HCC. After several randomized controlled trials (RCTs) that have attem…

Carcinoma HepatocellularNivolumabSurvivalSystemic therapyHepatocellular carcinomaLiver NeoplasmsSequential therapyHumansImmunotherapySorafenibTumor progression
researchProduct

Early Vascular Aging in Normotensive Patients With Systemic Lupus Erythematosus

2015

Connective tissue diseases, like systemic lupus erythematosus (SLE), are associated with early and accelerated atherosclerosis. Recently, the concept of “early vascular aging” (EVA) has been more widely accepted. Aortic stiffness is one of the important markers of EVA. We evaluated EVA and subclinical atherosclerosis, by measuring aortic pulse wave velocity (aPWV) and carotid intima–media thickness (cIMT), in 50 normotensive patients with SLE (mean age: 39 ± 12 years). We compared these participants with 50 age- and sex-matched patients with essential hypertension (EH) and 20 healthy controls. Each participant underwent 24-hour ambulatory blood pressure monitoring (ABPM), aPWV, and cIMT me…

Carotid Artery DiseasesMaleSettore MED/09 - Medicina InternaSLEBlood Pressure030204 cardiovascular system & hematologyEssential hypertensionCarotid Intima-Media Thickness0302 clinical medicineRisk FactorsLupus Erythematosus SystemicUltrasonography Doppler Colorskin and connective tissue diseasesPulse wave velocityAge FactorsBlood Pressure Monitoring AmbulatoryMiddle Agedcardiovascular systemCardiologyFemaleVascular agingAortic stiffnessEssential HypertensionCardiology and Cardiovascular MedicineAdultmedicine.medical_specialtyAmbulatory blood pressurePulse Wave AnalysisRenal Circulation03 medical and health sciencesVascular StiffnessInternal medicinemedicineHumansIn patientSettore MED/14 - Nefrologia030203 arthritis & rheumatologyAccelerated atherosclerosisbusiness.industryAtherosclerosismedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareSettore MED/16 - ReumatologiaCase-Control StudiesSubclinical atherosclerosisAsymptomatic DiseasesVASCULAR DAMAGEAORTIC STIFFFNESSEARLY VASCULAR AGINGVascular ResistancebusinessAngiology
researchProduct

Rethinking the sGLOH Descriptor

2018

sGLOH (shifting GLOH) is a histogram-based keypoint descriptor that can be associated to multiple quantized rotations of the keypoint patch without any recomputation. This property can be exploited to define the best distance between two descriptor vectors, thus avoiding computing the dominant orientation. In addition, sGLOH can reject incongruous correspondences by adding a global constraint on the rotations either as an a priori knowledge or based on the data. This paper thoroughly reconsiders sGLOH and improves it in terms of robustness, speed and descriptor dimension. The revised sGLOH embeds more quantized rotations, thus yielding more correct matches. A novel fast matching scheme is a…

Cascade matching0209 industrial biotechnologyHistogram binarizationRFDComputer scienceGLOHComputingMethodologies_IMAGEPROCESSINGANDCOMPUTERVISION02 engineering and technologyCNN descriptorLIOP020901 industrial engineering & automationMROGHArtificial IntelligenceRobustness (computer science)Keypoint matchingSIFTHistogram0202 electrical engineering electronic engineering information engineeringSettore ING-INF/05 - Sistemi Di Elaborazione Delle InformazioniSettore INF/01 - Informaticabusiness.industryApplied MathematicsCognitive neuroscience of visual object recognitionPattern recognitionRotation invariant descriptorsGLOHMIOPComputational Theory and MathematicsKeypoint matching SIFT sGLOH RFDs LIOP MIOP MROGH CNN descriptors rotation invariant descriptors histogram binarization cascade matchingPrincipal component analysis020201 artificial intelligence & image processingComputer Vision and Pattern RecognitionArtificial intelligencebusinessSoftware
researchProduct

Properties Augmentation of Cast Hypereutectic Al–Si Alloy Through Friction Stir Processing

2022

AbstractThe present endeavour is to augment mechanical attributes via friction stir processing (FSP) in hypereutectic aluminium–silicon castings by the means of microstructural modifications and defects reduction. Wherein, the study proceeds with mainly two approaches namely, alteration in tool revolution (TR) and the number of FSP passes. The prepared specimens were evaluated investigating volume fraction of porosities, microstructural characterizations and microhardness. Therefrom, the specimen with highest number of passes delivered most uniform properties resulting from the reduction in casting porosities and refined silicon particle uniform distribution throughout friction stir process…

Casting modification; Materials processing; Friction stir processing; Aluminium; Porosity; Grain refinementMechanics of MaterialsMetals and AlloysMetallurgy and Metallic MaterialsMaterials ChemistryMaterialkemiAluminium Casting modification Friction stir processing Grain refinement Materials processing PorosityMetallurgi och metalliska materialCondensed Matter PhysicsSettore ING-IND/16 - Tecnologie E Sistemi Di Lavorazione
researchProduct